NTIC

NORTHERN TECHNOLOGIES INTERNATIONAL CORP

Basic Materials | Micro Cap

$0.05

EPS Forecast

$25.23

Revenue Forecast

Announcing earnings for the quarter ending 2026-08-31 soon

NTIC 2022 Results: Momentum Across Zerust and Natur-Tec, but Watchful Winds Ahead for NTIC’s Global Reach

Reported by NTIC (ticker: NTIC) for the year ended August 31, 2022. EPS: $0.66 diluted; revenue: $74.159 million. No EPS consensus or formal revenue forecast disclosed in the release.

Executive snapshot: a year of record sales and strategic moves

Northern Technologies International Corporation (NTIC) closed fiscal 2022 with a glossy headline: consolidated net sales up 31.3% to a record $74.159 million, and net income attributable to NTIC at $6.325 million, translating to $0.66 per diluted share. The top-line strength was broad-based, led by Zerust Industrial and the Natur-Tec line, underscored by a full-year run that benefited from NTIC’s early 2022 purchase of the remaining 50% stake in Zerust India.

The company also disclosed a quarterly cadence that reflected ongoing demand, with NTIC posting $20.252 million in consolidated net sales for the three months ended August 31, 2022, up from $15.513 million a year earlier. Diluted earnings per share for the full year rose modestly to $0.66 from $0.64, signaling margin discipline alongside growth in value-added product lines.

Segment highlights: where the fuel came from—and where it pulled back

  • ZERUST industrial net sales rose to $57.459 million (40-ish percent of the total, if you’re eyeballing the mix), with a 26.1% year-over-year lift. The implied momentum in corrosion-inhibiting products remains a core driver.
  • ZERUST oil and gas net sales increased 21.5% to $4.608 million, underscoring ongoing demand in energy-related applications.
  • NTIC China net sales dipped 9.2% to $15.754 million, a reminder that the company’s exposure to international markets and localized cycles still matters in a post-pandemic recovery arc.
  • Natur-Tec product net sales surged 52.7% to $16.700 million, signaling meaningful traction for NTIC’s bio-based and biodegradable polymer resin offerings.
  • Joint venture operating income declined 21.9% to $10.494 million, a column that hints at cost or mix pressures outside core product success—worth watching as a potential drag on group margins.

On the bottom line, NTIC’s consolidated net income rose to $6.325 million for the year, with the cash position at $5.334 million as of August 31, 2022. The balance between growth engines (Zerust and Natur-Tec) and geographies—particularly the China exposure—frames the year’s overall risk-reward profile.

Management commentary: momentum with a caveat

Chief Executive Officer G. Patrick Lynch framed fiscal 2022 as a year of “record sales” driven by Zerust Industrial demand in North America and continued strength in Natur-Tec, plus Zerust Oil & Gas in U.S. and international markets. He attributed part of the gains to the India joint venture acquisition completed at the start of fiscal 2022, suggesting that geographic diversification helped NTIC navigate a challenging macro backdrop—characterized by supply chain frictions and rising raw material costs.

Looking ahead, the leadership signaled continued momentum across North American Zerust Industrial and global Zerust Oil & Gas and Natur-Tec markets. The tone implied an intent to improve profitability in fiscal 2023 through margin discipline and product mix optimization, even as European and Asian markets could present near-term headwinds.

What the numbers imply for NTIC and peers

The year’s growth story is anchored in a diversified mix: resilient corrosion-protection demand (Zerust), stronger sustainability-oriented polymers (Natur-Tec), and strategic regional expansion (notably Zerust India after the stake purchase). The non-GAAP cast of the numbers sits behind a simple narrative: revenue growth is real, and some operating segments performed better than others.

The decline in NTIC China revenue, contrasted with double-digit gains elsewhere, serves as a reminder that macroeconomic and policy environments can still tilt regional performance. For sector peers—players in corrosion inhibitors, sustainable polymers, and related industrial tech—the NTIC story reinforces that a balanced exposure to growth markets and resilient end-markets matters as much as raw sales growth itself.

Selective numbers at a glance

  • Full-year consolidated net sales: $74.159 million (up 31.3% YoY)
  • Net income attributable to NTIC: $6.325 million
  • EPS (diluted): $0.66
  • Cash and cash equivalents: $5.334 million
  • Three months ended Aug. 31, 2022 net sales: $20.252 million (vs. $15.513 million in 2021)
  • Key growth drivers: Zerust Industrial, Natur-Tec, Zerust Oil & Gas

Importantly, the release notes an acquisition-related lift in the prior-year comparison (the September 2021 acquisition of the remaining 50% stake in Zerust India). The company reports a strong top-line backdrop but also notes a year-over-year margin comparison that reflects both organic growth and integration effects from acquisitions.

The filing does not include a stated revenue forecast or an EPS consensus from external analysts, so investors looking for a formal street estimate would need to triangulate from external sell-side coverage or await guidance in upcoming quarters. In this context, “earnings surprise” cannot be adjudicated from the filing itself without a published EPS consensus; the company’s own EPS of $0.66 for the year is the reference point.

Forward look: what to watch next

The management tone suggests steady demand for Zerust Industrial and Natur-Tec supported by ongoing diversification into global markets. A key question for investors and peers alike: will fiscal 2023 deliver margin expansion as the company hinted, or will raw material costs and cross-border dynamics compress profitability despite volume gains?

For sector peers, NTIC’s experience highlights several themes: - Geographic diversification can blunt regional weakness but adds execution complexity and currency considerations. - Growth in sustainability-focused products (Natur-Tec) can offset traditional industrial cycles, particularly when buyers weigh environmental profiles in procurement decisions. - Joint ventures and acquisitions can materially alter the year-over-year comparisons, so investors should parse pro forma effects when comparing consecutive years.

Watch for any updated guidance on revenue outlook and margin targets in NTIC’s next quarterly release. Absent a formal revenue forecast, the market will likely anchor expectations to quarterly trends, backlog, and the trajectory of raw material costs as global supply chains normalize.

Conclusion: a solid year with a cautious horizon

NTIC’s 2022 results underscore a company that found momentum in its core corrosion-protection and sustainable polymer businesses, amplified by a strategic geographic expansion. The year delivered a record sales milestone and a modest uplift in EPS, even as China-facing revenue softened and operating income from joint ventures pressed lower. The absence of a formal EPS consensus and revenue forecast in the release means the stock’s near-term valuation will hinge on macro dynamics, execution efficiency, and the pace at which the company can translate mix into margin gains.

In the broader landscape of small-cap industrials focused on specialty chemicals and materials, NTIC’s narrative fits a pattern: growth is real when you can pair durable end-market demand with disciplined cost management and prudent global diversification. If fiscal 2023 proves the margins can widen while revenue remains on an upward trajectory, the company could extend its recent momentum into a broader set of industrials peers—without needing to reinvent the wheel, just re-tire the axle.

Note: This article references NTIC’s fiscal 2022 results and the accompanying statements. The piece includes live data such as EPS, net sales, and regional performance as disclosed by NTIC. No external EPS consensus or revenue forecast was provided in the filing.